0001405064-18-000004.txt : 20180302 0001405064-18-000004.hdr.sgml : 20180302 20180301183604 ACCESSION NUMBER: 0001405064-18-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(7) FILED AS OF DATE: 20180302 DATE AS OF CHANGE: 20180301 EFFECTIVENESS DATE: 20180302 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BRADMER PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001405064 IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-306793 FILM NUMBER: 18659439 BUSINESS ADDRESS: STREET 1: 1200 MCGILL COLLEGE AVENUE STREET 2: SUITE 1100 CITY: MONTREAL, QUEBEC STATE: A8 ZIP: H3B 4G7 BUSINESS PHONE: 514-390-2330 MAIL ADDRESS: STREET 1: 365 BAY STREET STREET 2: SUITE 800 CITY: TORONTO, ONTARIO STATE: A6 ZIP: M5H 2V1 D 1 primary_doc.xml X0708 D LIVE 0001405064 BRADMER PHARMACEUTICALS INC Wildeboer Dellelce Place, Suite 800 365 Bay St. Toronto A6 ONTARIO, CANADA M5H 2V1 416-847-6905 ONTARIO, CANADA None None Corporation true Paul Van Damme 339 Cranbrooke Avenue Toronto A6 ONTARIO, CANADA M5M1N2 Executive Officer Chief Financial Officer Dale Boden 2326 Longest Avenue Louisville KY KENTUCKY 40204 Director Robert Tessarolo 1240 White Lane Oakville A6 ONTARIO, CANADA M5H 2V1 Director Chuck Lilly 639 Moonrock Avenue Sudbury A6 ONTARIO, CANADA P3E 5Z6 Director Alan Ezrin 1827 South Bayshore Lane Miami FL FLORIDA 33133 Executive Officer Director Director, President Pharmaceuticals No Revenues 06b 3C 3C.7 false 2018-02-14 false true true true true 350000 GMP Securities L.P. None Griffiths McBurney Corp. 40620 145 King Street W Suite 300 Toronto A6 ONTARIO, CANADA M5H 1J8 NY NEW YORK false 38474998 38474998 0 false 25 1050000 true 0 0 false BRADMER PHARMACEUTICALS INC Paul Van Damme Paul Van Damme Chief Financial Officer 2018-03-01